Home › Funds › JOHNSON & JOHNSON › VOR
JOHNSON & JOHNSON position in VOR
VOR BIOPHARMA INC · Health Care
JOHNSON & JOHNSON reported holding 53,732 shares of VOR (VOR BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$1.0M, representing 0.13% of its reported portfolio and ranking #13 among its reported holdings. JOHNSON & JOHNSON has disclosed VOR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How JOHNSON & JOHNSON's VOR position evolved
JOHNSON & JOHNSON first disclosed a stake in VOR in Q3 2023 at 1,074,658 shares (US$2.3M). The position peaked in Q3 2025 at 53,732 shares, worth US$2.6M. Across 13 filings, JOHNSON & JOHNSON increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 53,732 shares valued at US$1.0M. Notable position changes include a 95% trim in Q3 2025 (shares fell 73% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.07M | $2.28M | New |
| Q4 2023 | 1.07M | $2.42M | Hold |
| Q1 2024 | 1.07M | $2.55M | Hold |
| Q2 2024 | 1.07M | $1.07M | Hold |
| Q3 2024 | 1.07M | $752.26K | Hold |
| Q4 2024 | 1.07M | $1.19M | Hold |
| Q1 2025 | 1.07M | $771.07K | Hold |
| Q2 2025 | 1.07M | $1.14M | Hold |
| Q3 2025 | 53.73K | $2.62M | Reduce |
| Q4 2025 | 53.73K | $702.82K | Hold |
| Q1 2026 | 53.73K | $958.58K | Hold |
| Q2 2026 | 53.73K | $989.21K | Hold |
| Q3 2026 | 53.73K | $1.03M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VOR and 13F data
VOR (VOR BIOPHARMA INC) is a Health Care company. 75 other funds we track also report a position in VOR — the largest reported positions include TCG Crossover Management, LLC (US$104.4M), FCPM III SERVICES B.V. (US$75.8M), Venrock Adviser, LLC (US$56.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VOR
- TCG Crossover Management, LLC 5.67M sh · $104.44M · Q2 2026
- FCPM III SERVICES B.V. 4.12M sh · $75.80M · Q2 2026
- Venrock Adviser, LLC 3.04M sh · $56.00M · Q2 2026
- Frazier Life Sciences Management, L.P. 2.54M sh · $46.83M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 2.40M sh · $44.22M · Q2 2026
- Caligan Partners LP 1.93M sh · $35.44M · Q2 2026
- Paradigm Biocapital Advisors LP 1.75M sh · $32.22M · Q2 2026
- GREAT POINT PARTNERS LLC 1.70M sh · $31.30M · Q2 2026
- Nantahala Capital Management, LLC 845.00K sh · $15.56M · Q2 2026
- NAN FUNG TRINITY (HK) Ltd 721.55K sh · $13.77M · Q3 2026
- ADAR1 Capital Management, LLC 680.63K sh · $12.53M · Q2 2026
- Logos Global Management LP 650.00K sh · $11.97M · Q2 2026
More on JOHNSON & JOHNSON
FAQ
How long has JOHNSON & JOHNSON held VOR?
JOHNSON & JOHNSON has disclosed VOR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is JOHNSON & JOHNSON's current position in VOR?
As of Q3 2026, JOHNSON & JOHNSON holds 53.73K shares of VOR (VOR BIOPHARMA INC), valued at $1.03M, representing 0.13% of its reported portfolio and ranking #13.
Has JOHNSON & JOHNSON been buying or selling VOR?
In the latest 13F filing (Q3 2026), JOHNSON & JOHNSON held unchanged its position in VOR. The position peaked in Q3 2025 at 53.73K shares.
Which other funds hold VOR?
Other major institutional holders of VOR include TCG Crossover Management, LLC, FCPM III SERVICES B.V., Venrock Adviser, LLC, among 75 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.